Location History:
- Viareggio (LU), IT (2002)
- Pisa, IT (2000 - 2008)
Company Filing History:
3 out of 4 
1 out of 832,812 Years Active: 2000-2008
Title: Innovations by Boris Giannaccini
Introduction
Boris Giannaccini is a notable inventor based in Pisa, Italy. He has made significant contributions to the field of ophthalmic and antimicrobial compositions. With a total of four patents to his name, Giannaccini's work focuses on improving treatments for various medical conditions.
Latest Patents
One of his latest patents is an ophthalmic composition containing N-acetyl-cysteine for the treatment of dry-eye syndrome. This innovative formulation includes acetylcysteine as the active ingredient, which has a mucolitic action suitable for administration in eyedrops. The composition is designed to maintain pH levels between 6.0 and 7.5 and has a physiologically acceptable osmolarity of less than 320 mOsm/kg. This formulation aims to avoid the irritative effects associated with previous products containing N-acetyl-cysteine.
Another significant patent by Giannaccini involves bioadhesive complexes of polycarbophil and azole antifungal or antiprotozoal drugs. These mucoadhesive antimicrobial complexes are intended for the topical treatment of mucosal affections. The formulation process involves dissolving the starting products in a common solvent, combining them, and then processing the resulting product into a gel for sustained release antifungal applications.
Career Highlights
Throughout his career, Giannaccini has worked with various companies, including Farmigea S.p.a. His innovative approaches and dedication to research have led to advancements in pharmaceutical formulations.
Collaborations
Giannaccini has collaborated with notable professionals in his field, including Marco Fabrizio Saettone and Enrico Boldrini. These collaborations have contributed to the development of his patented inventions.
Conclusion
Boris Giannaccini's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving medical treatments. His work continues to influence the development of effective therapeutic solutions.